Loading clinical trials...
Loading clinical trials...
A Phase II Study of High-Dose Melphalan With Hematopoietic Stem Cell Reconstitution for Patients With Primary Systemic Amyloidosis
Conditions
Interventions
filgrastim
melphalan
+2 more
Locations
17
United States
CCOP - Scottsdale Oncology Program
Scottsdale, Arizona, United States
Sylvester Cancer Center, University of Miami
Miami, Florida, United States
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
CCOP - Evanston
Evanston, Illinois, United States
CCOP - Illinois Oncology Research Association
Peoria, Illinois, United States
Indiana University Cancer Center
Indianapolis, Indiana, United States
Start Date
November 16, 1998
Primary Completion Date
December 1, 2002
Last Updated
June 22, 2023
NCT07319897
NCT00305812
NCT00002878
NCT00726830
NCT00534118
NCT00084747
Lead Sponsor
Eastern Cooperative Oncology Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions